June 13, 2023
Over the past several years, the U.S. Drug Enforcement Administration has seen a sharp increase in the trafficking of fentanyl mixed with xylazine. Xylazine, also known as “Tranq,” is a powerful sedative that the U.S. Food and Drug Administration has approved for veterinary use. Xylazine and fentanyl drug mixtures place users at a higher risk of suffering a fatal drug poisoning. Because xylazine is not an opioid, naloxone (Narcan) does not reverse its effects.
Join us for the next installment of the California Medical Association’s Virtual Grand Rounds — Fentanyl and "Tranq" (Xyazine) - Emerging Threats in Illicit Drug Use — to hear about the latest data about this rapidly evolving crisis on our streets. The free one-hour webinar will be July 11, 2023, at 12 p.m Pacific time.
Our speakers will include Robin Christensen, Chief of the California Department of Public Health Substance and Addiction Prevention Branch, and Jeffrey Hom, M.D., MPH, Director of Population Behavioral Health for the San Francisco Department of Public Health. And as always, we will be joined by California State Epidemiologist Erica Pan, M.D., MPH, and moderator Kimberly Newell Green, M.D.
Virtual Grand Rounds: Emerging Public Health Issues is a free and monthly series providing the latest patient management news and resources. The effort is a partnership between CMA and the California Health and Human Services Agency (CalHHS), with the California Academy of Physician Assistants (CAPA) and the Osteopathic Physicians and Surgeons of California (OPSC).
If you are unable to attend the live event, it will be available for on-demand playback at cmagrandrounds.org.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the California Medical Association (CMA) and California Health and Human Services Agency. CMA is accredited by ACCME to provide continuing medical education for physicians.
The California Medical Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.